Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +17.01%
#3 Orochi Network Orochi Network +10.19%
#4 Pump.fun Pump.fun +9.55%
#5 Unit Pump Unit Pump +9.55%
#6 eCash eCash +9.31%
#7 Fake World Assets Fake World Assets +8.82%
#8 OPENLOOT OPENLOOT +8.48%
#9 Meteora Meteora +8.22%
#10 Glidr Glidr +8.12%
Coin of the day
PulseChain PulseChain
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc.

MRNS
Classement en actions #28040
Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated... Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated to the development and commercialization of therapeutic solutions for individuals suffering from rare genetic epilepsies and other seizure-related conditions. The company's primary commercialized product is ZTALMY, an oral suspension specifically designed to manage seizures associated with cyclin-dependent kinase-like 5 deficiency disorder (CDD). This medication is prescribed for both adult and pediatric patient populations, suitable for use in acute and chronic care settings, and can be administered either in-patient or by the patient themselves. ZTALMY exerts its effect by targeting synaptic and extrasynaptic GABAA receptors, a mechanism that also suggests potential anticonvulsant, antidepressant, and anxiolytic benefits. Beyond ZTALMY, Marinus is actively progressing ganaxolone through development, an investigational therapy aimed at various genetic epileptic conditions such as PCDH19-related epilepsy, tuberous sclerosis complex, and Lennox-Gastaut Syndrome, with additional exploration for depressive disorders. The company maintains strategic alliances, including licensing agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc., as well as a collaborative partnership with Orion Corporation. Marinus Pharmaceuticals was established in 2003 and operates from its corporate headquarters in Radnor, Pennsylvania.
Prix de l'action
$0.55
Dernière synchronisation: 2025-02-11
Capitalisation boursière
$28.90M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Marinus Pharmaceuticals, Inc. (MRNS)

Catégorie

Healthcare
Nombre d'actions en circulation pour Marinus Pharmaceuticals, Inc. (MRNS)
Nombre d'actions en circulation au September 2024: 57.23M
Selon les derniers rapports financiers et le cours de l'action de Marinus Pharmaceuticals, Inc., le nombre actuel d'actions en circulation est de 57.23M. À la fin de December 2022, l'entreprise avait 39.07M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de Marinus Pharmaceuticals, Inc. (MRNS) de 2012 à 2026
Actions en circulation à la fin de chaque année
Année Actions en circulation Changez
2026 (TTM) 57.23M 6.48%
2023 53.75M 37.56%
2022 39.07M 6.47%
2021 36.70M 34.57%
2020 27.27M 100.10%
2019 13.63M 33.30%
2018 10.22M 73.72%
2017 5.89M 20.73%
2016 4.87M 30.69%
2015 3.73M 142.49%
2014 1.54M -23.70%
2013 2.02M 0.00%
2012 2.02M 0.00%
Actions en circulation pour des entreprises similaires ou concurrentes
Entreprise Actions en circulation Différence Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 343.65%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 396.00M 591.95%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 8.66%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 483.58M 744.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH